152 related articles for article (PubMed ID: 16459502)
1. Cutaneous mycobacterial infection post intravesical BCG installation.
Ng YH; Bramwell SP; Palmer TJ; Woo WK
Surgeon; 2006 Feb; 4(1):57-8. PubMed ID: 16459502
[TBL] [Abstract][Full Text] [Related]
2. Pure squamous cell carcinoma after intravesical BCG treatment. A case report.
Yurdakul T; Avunduk MC; Piskin MM
Urol Int; 2005; 74(3):283-5. PubMed ID: 15812221
[TBL] [Abstract][Full Text] [Related]
3. Granulomatous hepatitis after intravesical BCG treatment for bladder cancer.
Ersoy O; Aran R; Aydinli M; Yonem O; Harmanci O; Akdogan B; Pinar A; Sokmensuer C; Bayraktar Y
Indian J Gastroenterol; 2006; 25(5):258-9. PubMed ID: 17090848
[TBL] [Abstract][Full Text] [Related]
4. [Enlarged pelvic lymph nodes after immunotherapy in a patient with bladder cancer].
Rissanen AM; Pekonen M; Terho R; Krees R; Katila ML
Duodecim; 2002; 118(10):1029-32. PubMed ID: 12237997
[No Abstract] [Full Text] [Related]
5. Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy.
Mizoguchi H; Iida O; Dohi T; Tomoda K; Kimura H; Inoue K; Iwata T; Tei K; Miura T
Ann Vasc Surg; 2013 Nov; 27(8):1186.e1-5. PubMed ID: 23972639
[TBL] [Abstract][Full Text] [Related]
6. Systemic BCG infection in a patient with pancytopaenia and fever 9 years after intravesical BCG administration for bladder cancer.
Westhovens IM; Vanden Abeele ME; Messiaen PE; van der Hilst JCh
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27170615
[TBL] [Abstract][Full Text] [Related]
7. Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy.
McParland C; Cotton DJ; Gowda KS; Hoeppner VH; Martin WT; Weckworth PF
Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1330-3. PubMed ID: 1443892
[TBL] [Abstract][Full Text] [Related]
8. BCG sepsis following inadvertent intravenous BCG administration for the treatment of bladder cancer can be effectively cured with anti-tuberculosis medications.
Akbulut Z; Canda AE; Atmaca AF; Cimen HI; Hasanoglu C; Balbay MD
N Z Med J; 2010 Nov; 123(1325):72-7. PubMed ID: 21317964
[TBL] [Abstract][Full Text] [Related]
9. [Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report].
Muranaka T; Kunishima Y; Shigyo M; Kato R; Masumori N; Ito N; Tsukamoto T; Takagi Y; Seki M; Toida I
Hinyokika Kiyo; 2007 Aug; 53(8):581-4. PubMed ID: 17874552
[TBL] [Abstract][Full Text] [Related]
10. [Rare, but significant complication after BCG instillation therapy after urothelial carcinoma].
Stahl T; Engelhardt F; Layer G
Rofo; 2013 Dec; 185(12):1199-200. PubMed ID: 23832635
[No Abstract] [Full Text] [Related]
11. Tuberculous orchiepididymitis after BCG therapy for bladder cancer.
Briceño-García EM; Gómez-Pardal A; Alvarez-Bustos G; Artero-Muñoz I; Molinero MM; Seara-Valero R; Moreno-Ramírez V
J Ultrasound Med; 2007 Jul; 26(7):977-9. PubMed ID: 17592062
[No Abstract] [Full Text] [Related]
12. Long-term follow-up of intravesical bacillus Calmette-Guérin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra.
Taylor JH; Davis J; Schellhammer P
Clin Genitourin Cancer; 2007 Sep; 5(6):386-9. PubMed ID: 17956711
[TBL] [Abstract][Full Text] [Related]
13. Disseminated tuberculosis in a patient with recurrent transitional cell carcinoma of renal pelvis and bladder following intravesical BCG therapy: A report of a rare case.
Pujani M; Khan S; Jetley S; Raina PK
J Cancer Res Ther; 2015; 11(4):1028. PubMed ID: 26881604
[TBL] [Abstract][Full Text] [Related]
14. Bacillus Calmette-Guérin-induced granulomatous hepatitis in a patient with a superficial bladder carcinoma.
Van Outryve SM; Francque SM; Gentens PA; De Pauw FF; Van den Bogaert E; Van Marck EA; Pelckmans PA; Michielsen PP
Eur J Gastroenterol Hepatol; 2004 Oct; 16(10):1027-32. PubMed ID: 15371927
[TBL] [Abstract][Full Text] [Related]
15. [Systemic Bacillus Calmette-Guerin sepsis manifesting as autoimmunity, 17 months after an intravesical BCG-therapy].
Goulabchand R; Dufour S; Murez T; Broner J; Rivière S; Guilpain P; Le Quellec A
Med Mal Infect; 2017 Dec; 47(8):558-561. PubMed ID: 28943176
[No Abstract] [Full Text] [Related]
16. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.
Hoag N; Pommerville PJ; Kibsey PC; Cavers DJ; Eddy RJ
Can J Urol; 2009 Apr; 16(2):4589-91. PubMed ID: 19364433
[TBL] [Abstract][Full Text] [Related]
17. Reiter's syndrome postintravesical Bacillus Calmette-Guérin instillations.
Ng KL; Chua CB
Asian J Surg; 2017 Apr; 40(2):163-165. PubMed ID: 25183290
[TBL] [Abstract][Full Text] [Related]
18. Systemic effects of intravesical BCG treatment.
Little B; Young MR; Convery R
Ir J Med Sci; 2002; 171(3):174, 177. PubMed ID: 15736366
[No Abstract] [Full Text] [Related]
19. Id-like reaction to BCG therapy for bladder cancer.
Lowther C; Miedler JD; Cockerell CJ
Cutis; 2013 Mar; 91(3):145-6, 151. PubMed ID: 23617086
[TBL] [Abstract][Full Text] [Related]
20. BCG pyelonephritis following intravesical therapy for transitional cell carcinoma.
Garcia JE; Thiel DD; Broderick GA
Can J Urol; 2007 Apr; 14(2):3523-5. PubMed ID: 17466161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
